Patents by Inventor John Edgar Dick

John Edgar Dick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
    Publication number: 20200207861
    Abstract: A method for inhibition of leukemic stem cells expressing IL-3R? (CD123), comprises contacting the cells with an antigen binding molecule comprising a Fc region or a modified Fc region having enhanced Fc effector function, wherein the antigen binding molecule binds selectively to IL-3R? (CD123). The invention includes the treatment of a hematologic cancer condition in a patient by administration to the patient of an effective amount of the antigen binding molecule.
    Type: Application
    Filed: July 19, 2019
    Publication date: July 2, 2020
    Applicants: CSL Limited, University Health Network
    Inventors: John Edgar DICK, Liqing Jin, Gino Luigi VAIRO, David Paul Gearing, Samantha Jane Busfield
  • METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
    Publication number: 20180079818
    Abstract: A method for inhibition of leukemic stem cells expressing IL-3R? (CD123), comprises contacting the cells with an antigen binding molecule comprising a Fc region or a modified Fc region having enhanced Fc effector function, wherein the antigen binding molecule binds selectively to IL-3R? (CD123). The invention includes the treatment of a hematologic cancer condition in a patient by administration to the patient of an effective amount of the antigen binding molecule.
    Type: Application
    Filed: May 5, 2017
    Publication date: March 22, 2018
    Applicants: CSL Limited, University Health Network
    Inventors: John Edgar Dick, Liqing JIN, Gino Luigi VAIRO, David Paul GEARING, Samantha Jane BUSFIELD
  • METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
    Publication number: 20170029515
    Abstract: A method for inhibition of leukemic stem cells expressing IL-3R? (CD123), comprises contacting the cells with an antigen binding molecule comprising a Fc region or a modified Fc region having enhanced Fc effector function, wherein the antigen binding molecule binds selectively to IL-3R? (CD123). The invention includes the treatment of a hematologic cancer condition in a patient by administration to the patient of an effective amount of the antigen binding molecule.
    Type: Application
    Filed: August 10, 2016
    Publication date: February 2, 2017
    Applicants: CSL Limited, University Health Network
    Inventors: John Edgar Dick, Liqing JIN, Gino Luigi VAIRO, David Paul GEARING, Samantha Jane BUSFIELD
  • METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
    Publication number: 20150152185
    Abstract: A method for inhibition of leukemic stem cells expressing IL-3R.alpha.; (CD 123), comprises contacting the cells with an antigen binding molecule comprising a Fc region or a modified Fc region having enhanced Fc effector function, wherein the antigen binding molecule binds selectively to IL-3R.alpha. (CD123). The invention includes the treatment of a hematologic cancer condition in a patient by administration to the patient of an effective amount of the antigen binding molecule.
    Type: Application
    Filed: November 25, 2014
    Publication date: June 4, 2015
    Applicants: CSL LIMITED, UNIVERSITY HEALTH NETWORK
    Inventors: JOHN EDGAR DICK, LIQING JIN, GINO LUIGI VAIRO, DAVID PAUL GEARING, SAMANTHA JANE BUSFIELD
  • METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
    Publication number: 20130230510
    Abstract: A method for inhibition of leukemic stem cells expressing IL-3R.alpha.; (CD 123), comprises contacting the cells with an antigen binding molecule comprising a Fc region or a modified Fc region having enhanced Fc effector function, wherein the antigen binding molecule binds selectively to IL-3R.alpha. (CD123). The invention includes the treatment of a hematologic cancer condition in a patient by administration to the patient of an effective amount of the antigen binding molecule.
    Type: Application
    Filed: December 4, 2012
    Publication date: September 5, 2013
    Applicants: University Health Network, CSL Limited
    Inventors: John Edgar Dick, Liqing Jin, Gino Luigi Vairo, David Paul Gearing, Samantha Jane Busfield
  • METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
    Publication number: 20110052574
    Abstract: A method for inhibition of leukemic stem cells expressing IL-3R?; (CD 123), comprises contacting the cells with an antigen binding molecule comprising a Fc region or a modified Fc region having enhanced Fc effector function, wherein the antigen binding molecule binds selectively to IL-3R? (CD123). The invention includes the treatment of a hematologic cancer condition in a patient by administration to the patient of an effective amount of the antigen binding molecule.
    Type: Application
    Filed: December 4, 2008
    Publication date: March 3, 2011
    Inventors: John Edgar Dick, Liqing Jin, Gino Luigi Vairo, David Paul Gearing, Samantha Jane Busfield